V

Viol Co Ltd
KOSDAQ:335890

Watchlist Manager
Viol Co Ltd
KOSDAQ:335890
Watchlist
Price: 7 860 KRW -2.24% Market Closed
Market Cap: 453.9B KRW
Have any thoughts about
Viol Co Ltd?
Write Note

Viol Co Ltd
Other Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Viol Co Ltd
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
V
Viol Co Ltd
KOSDAQ:335890
Other Items
-â‚©1.7B
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Biodyne Co Ltd
KOSDAQ:314930
Other Items
-â‚©1B
CAGR 3-Years
N/A
CAGR 5-Years
-59%
CAGR 10-Years
N/A
I
I Sens Inc
KOSDAQ:099190
Other Items
-â‚©33.9B
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Other Items
-â‚©50.9B
CAGR 3-Years
N/A
CAGR 5-Years
-244%
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Other Items
-â‚©29.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Other Items
â‚©8.8B
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
12%
No Stocks Found

Viol Co Ltd
Glance View

Market Cap
453.9B KRW
Industry
Health Care

VIOL Co., Ltd. is engaged in the provision of financial support services. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-12-03. The firm's main product is Scarlet, an equipment for elasticity and lifting. In addition, the Company develops and produces medical devices for anti-aging skin care. The firm sells its products in domestic and overseas markets such as China and the United States.

Intrinsic Value
12 206.45 KRW
Undervaluation 36%
Intrinsic Value
Price
V

See Also

What is Viol Co Ltd's Other Items?
Other Items
-1.7B KRW

Based on the financial report for Dec 31, 2023, Viol Co Ltd's Other Items amounts to -1.7B KRW.

What is Viol Co Ltd's Other Items growth rate?
Other Items CAGR 3Y
23%

Over the last year, the Other Items growth was 78%. The average annual Other Items growth rates for Viol Co Ltd have been 23% over the past three years .

Back to Top